Trial · NCT03004924
Results by group129
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 129
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Clinical Resolution Among Who Received SHP640 or Placebo on Day 5 | SHP640 | 111 | Participants | ||
| Number of Participants With Clinical Resolution Among Who Received SHP640 or Placebo on Day 5 | PVP-I 0.6% | 0 | Participants | ||
| Number of Participants With Clinical Resolution Among Who Received SHP640 or Placebo on Day 5 | Placebo | 95 | Participants | ||
| Number of Participants With Bacterial Eradication Among Who Received SHP640 or Placebo on Day 5 | SHP640 | 94 | Participants | ||
| Number of Participants With Bacterial Eradication Among Who Received SHP640 or Placebo on Day 5 | PVP-I 0.6% | 0 | Participants | ||
| Number of Participants With Bacterial Eradication Among Who Received SHP640 or Placebo on Day 5 | Placebo | 102 | Participants | ||
| Number of Participants With Clinical Resolution | SHP640 | Day 3 | 39 | Participants | |
| Number of Participants With Clinical Resolution | PVP-I 0.6% | Day 3 | 6 | Participants | |
| Number of Participants With Clinical Resolution | Placebo | Day 3 | 39 | Participants | |
| Number of Participants With Clinical Resolution | SHP640 | Day 8 | 148 | Participants | |
| Number of Participants With Clinical Resolution | PVP-I 0.6% | Day 8 | 39 | Participants | |
| Number of Participants With Clinical Resolution | Placebo | Day 8 | 133 | Participants | |
| Number of Participants With Clinical Resolution | SHP640 | Day 12 | 150 | Participants | |
| Number of Participants With Clinical Resolution | PVP-I 0.6% | Day 12 | 47 | Participants | |
| Number of Participants With Clinical Resolution | Placebo | Day 12 | 154 | Participants | |
| Number of Participants With Bacterial Eradication | SHP640 | Day 3 | 76 | Participants | |
| Number of Participants With Bacterial Eradication | PVP-I 0.6% | Day 3 | 33 | Participants | |
| Number of Participants With Bacterial Eradication | Placebo | Day 3 | 79 | Participants | |
| Number of Participants With Bacterial Eradication | SHP640 | Day 8 | 85 | Participants | |
| Number of Participants With Bacterial Eradication | PVP-I 0.6% | Day 8 | 25 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03004924/results